Siemens Healthineers (SMMNY) Projected to Post Earnings on Friday

Siemens Healthineers (OTCMKTS:SMMNY) is expected to be posting its resultson Friday, July 31st. Analysts expect Siemens Healthineers to announce earnings of $0.3022 per share and revenue of $6.4503 billion for the quarter.

Siemens Healthineers (OTCMKTS:SMMNY) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.02. The firm had revenue of $6.68 billion during the quarter, compared to the consensus estimate of $6.96 billion.

Siemens Healthineers Stock Performance

OTCMKTS SMMNY opened at $19.32 on Friday. Siemens Healthineers has a 52 week low of $19.20 and a 52 week high of $28.92. The business has a 50 day moving average price of $19.84 and a 200-day moving average price of $22.04.

Analysts Set New Price Targets

Separately, Zacks Research lowered shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.